Inventor
GROSS STEVEN S
US20 patents
⚠️ This page may combine multiple inventors who share the name “GROSS STEVEN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORNELL RES FOUNDATION INC
8 patentsUS5877176AMar 2, 1999
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC43 citations96
US6274581B1Aug 14, 2001
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC25 citations92
US6153615ANov 28, 2000
Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC28 citations92
US5874433AFeb 23, 1999
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC19 citations92
US5502050AMar 26, 1996
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC37 citations92
US5395612AMar 7, 1995
Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an α1 adrenergic agonist
CORNELL RES FOUNDATION INC22 citations91
US5880124AMar 9, 1999
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
CORNELL RES FOUNDATION INC13 citations74
US6784178B2Aug 31, 2004
Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity
CORNELL RES FOUNDATION INC12 citations66
UNIV TEXAS
8 patentsUS5334380AAug 2, 1994
Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
UNIV TEXAS58 citations96
US5216025AJun 1, 1993
Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
UNIV TEXAS64 citations95
US5374651ADec 20, 1994
Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
UNIV TEXAS36 citations92
US5286739AFeb 15, 1994
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
UNIV TEXAS35 citations92
US5312835AMay 17, 1994
Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
UNIV TEXAS7 citations73
US5776979AJul 7, 1998
Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
UNIV TEXAS2 citations62
US5770623AJun 23, 1998
Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
UNIV TEXAS2 citations62
US5534545AJul 9, 1996
Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production
UNIV TEXAS1 citations52
WISCONSIN MED COLLEGE INC
2 patentsUS5723448AMar 3, 1998
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
WISCONSIN MED COLLEGE INC11 citations74
US5545625AAug 13, 1996
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
WISCONSIN MED COLLEGE INC11 citations74